Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 13
Original Research
A Phase II single-arm trial of palonosetron for the prevention of acute and delayed chemotherapy-induced nausea and vomiting in malignant glioma patients receiving multidose irinotecan in combination with bevacizumab
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 10,894 | Dovepress* | 10,264+ | 1,923 | 12,187 | |
| PubMed Central* | 630 | 211 | 841 | ||
| Totals | 10,894 | 2,134 | 13,028 | ||
| *Since 23 December 2016 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 2 | 0 | 0 | 0 | 1 | 1 |
View citations on PubMed Central and Google Scholar